𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo molecular imaging

✍ Scribed by R.J. Gillies


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
314 KB
Volume
87
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


The relatively young field of molecular imaging is focused on the visualization of molecular phenotypes in whole organisms. This is achieved using imaging systems based on radionuclides, nuclear magnetic resonance, ultrasound, or the visible-IR region of the optical spectrum. Molecularly defined contrast in these modalities is generated by exogenous probes of the endogenous proteome, or through transgenes. Examples of exogenous probes include those that are transported and trapped (glucose, nucleoside analogs), those directed against extracellular receptors (somatostatin, opioid, melanotropin), and those activated by extracellular proteases. Transgenes that have been used in molecular imaging include the above receptors, non-mammalian enzymes that trap pro-drugs (HSV-tk, yeast CD), and optical reporter proteins (luciferase, fluorescent proteins). Cutting edge technologies in this field include in vivo assays for protein-protein interactions, and in vivo assays for mRNA expression patterns. The number of degrees of freedom in designing new agents is daunting, and advancements in this field will require a significant participation from molecular and cellular biochemists.


📜 SIMILAR VOLUMES


In vivo molecular-genetic imaging
✍ Ronald G. Blasberg; Juri Gelovani-Tjuvajev 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

Noninvasive in vivo molecular-genetic imaging has developed over the past decade and involves nuclear (PET, gamma camera), magnetic resonance, and in vivo optical imaging systems. Although three different imaging strategies - "direct," "indirect" and "surrogate" - are being used, most current in viv

NIR fluorescent ytterbium compound for i
✍ Kazuki Aita; Takashi Temma; Yuji Kuge; Koh-ichi Seki; Hideo Saji 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

## Abstract We have developed a new NIR fluorescent probe based on an ytterbium(III) (__E__)‐1‐(pyridin‐2‐yl‐diazenyl)naphthalen‐2‐ol (PAN) complex. This probe emits near‐infrared luminescence derived from the Yb ion through excitation of the PAN moiety with visible light (__λ__~ex~= 530 nm, __λ__~

In vivo biodistribution of stem cells us
✍ Mick M. Welling; Marjolijn Duijvestein; Alberto Signore; Louise van der Weerd 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB 👁 1 views

## Abstract Studies on stem cell are rapidly developing since these cells have great therapeutic potential for numerous diseases and has generated much promise as well as confusion due to contradictory results. Major questions in this research field have been raised as to how and in which numbers s

In vivo molecular imaging of adenoviral
✍ Brian T. Feeley; Augustine H. Conduah; Osamu Sugiyama; Lucie Krenek; Irvin S. Y. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 435 KB

## Abstract Regional gene therapy techniques are promising methods to enhance bone formation in large bone defects that would be difficult to treat with allograft or autograft bone stock. In this study, we compared in vivo temporal expression patterns of adenoviral‐ and lentiviral‐mediated gene the

Molecular imaging in prostate cancer
✍ Jose A. Karam; Ralph P. Mason; Kenneth S. Koeneman; Peter P. Antich; Elie A. Ben 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

## Abstract Prostate cancer (PCa) is the most common non‐cutaneous malignancy in men. New ways to diagnose this cancer in its early stages are needed. Unique genetic and biochemical changes in the cell pave the way for tumors to grow and metastasize. Novel imaging approaches attempt to detect patho

In vivo quantification of fluorescent mo
✍ A. Bogaards; H.J.C.M Sterenborg; J. Trachtenberg; B.C. Wilson; L. Lilge 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

## Abstract Future applications of “molecular diagnostic screening” and “molecular image‐guided surgery” will demand images of molecular markers with high resolution and high throughput (∼≥30 frames/second). MRI, SPECT, PET, optical fluorescence tomography, hyper‐spectral fluorescence imaging, and